3
Announcements
Trials
Browse
Landscape
Status
Completed
7
Unknown
4
Recruiting
2
Withdrawn
1
Enrolling by invitation
1
Sponsor Class
OTHER
5
OTHER_GOV
1
INDUSTRY
1
FED
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Neoplasms
12
Hematologic Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Prostatic Neoplasms
5
Urinary Bladder Neoplasms
4
Leukemia, Myeloid, Acute
4
Colorectal Neoplasms
4
Breast Neoplasms
4
Uterine Cervical Neoplasms
3
Myasthenia Gravis
3
Multiple Myeloma
3
Lung Neoplasms
3
Kidney Neoplasms
3
Carcinoma, Hepatocellular
3
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
Lymphoma
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Heart Failure
2
Glioma
2
Glioblastoma
2
Esophageal Neoplasms
2
Diabetes Mellitus, Type 2
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
INDUSTRY
×
Pulmonary Disease, Chronic Obstructive
×
Clear all
NCT06583395
2024-11-01
QUANTUM
VitaMed Research LLC
Enrolling by invitation
3,000 enrolled